-$0.37 (-5.21%)
12:00PM (15 mins delay)
Sep 15, 2009 - 10:29 AM EDT
optionMONSTER submits:By Jon "DRJ" Najarian
Partners in Four Countries
BioCryst (BCRX) Pharmaceuticals has signed letters of intent with three partners that will exclusively represent the company in selling its peramivir influenza treatment in four countries. The news has sent shares of BCRX running up from Monday's close of $10.73 to trade $12.38 Tuesday morning in pre-market trading on our Heat Seeker tracking system.
Source: Seeking Alpha (Sep 15, 2009 - 10:29 AM EDT)
© 2009 UpDown. All Rights Reserved.
Make a suggestion for this page
Data powered by QuoteMedia (Terms of Use). Data delayed 15 minutes unless otherwise indicated.
